The Jikei University School of Medicine · Graduate School of Medicine / Faculty of Medicine

Research keywordsurothelial carcinoma・prostate cancer・renal pelvis carcinoma・androgen receptor inhibitors・brachytherapy outcomes・immune checkpoint therapy・urologic oncology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• PP-752 腎集合管癌に対して分子標的薬を投与した2例の経験(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)
• Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
• 小径腎癌に対する経皮的凍結手術中の血圧上昇に関する検討
• Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.

• SUCLA2欠失がんの治療薬開発と臨床応用に向けた展開
• 去勢抵抗性前立腺癌におけるアンドロゲン受容体isoform及び癌関連遺伝子の検討
• SUCLA2遺伝子欠失を標的とする進行前立腺がんの新規治療法開発

• Official profile